It is important that the effects of each receptor are investigated in a cancer-specific manner as it is evident that Eph receptors do not always function the same way; EphA7, e.g., has a tumour-suppressive role in colorectal cancer and prostate cancer, but is tumour-promoting in NSCLC [35]. This evidence concerns the gene EPHA7 and prostate cancer.